NERVIANO MEDICAL SCIENCES PART OF NMS GROUP Trademark

Trademark Overview


On Friday, July 9, 2021, a trademark application was filed for NERVIANO MEDICAL SCIENCES PART OF NMS GROUP with the United States Patent and Trademark Office. The USPTO has given the NERVIANO MEDICAL SCIENCES PART OF NMS GROUP trademark a serial number of 79326491. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by NERVIANO MEDICAL SCIENCES S.R.L.. The NERVIANO MEDICAL SCIENCES PART OF NMS GROUP trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Education, namely, providing classes, courses, seminars, workshops, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing of training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing entertainment in the nature of exhibitions, live shows, online non-downloadable video and non-downloadable films via video-on-demand transmission services, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; educational services, namely, providing know-how transfer training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing online electronic publications, not downloadable, in the nature of books, magazines, and newsletters related to research and development, testing, manufacturing and market...

Pharmaceutical and veterinary preparations for treating cancer, myocardium infarction and malaria; sanitary preparations for medical purposes; biological preparations for medical purposes for the treatment of cancer, myocardium infarction and malaria; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, myocardium infarction and malaria; chemico-pharmaceutical preparations for the treatment of cancer, myocardium infarction and malaria; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of cancer, myocardium infarction and malaria; pharmaceuticals in the nature of anti-cancer preparations

Scientific, technological, analysis and research services, namely, scientific research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; medical and scientific research, namely, conducting clinical trials for others in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control for others in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies
nerviano medical sciences part of nms group

General Information


Serial Number79326491
Word MarkNERVIANO MEDICAL SCIENCES PART OF NMS GROUP
Filing DateFriday, July 9, 2021
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6993809
Registration DateTuesday, March 7, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements


Goods and ServicesEducation, namely, providing classes, courses, seminars, workshops, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing of training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing entertainment in the nature of exhibitions, live shows, online non-downloadable video and non-downloadable films via video-on-demand transmission services, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; educational services, namely, providing know-how transfer training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing online electronic publications, not downloadable, in the nature of books, magazines, and newsletters related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; publication of texts, other than publicity texts, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; arranging and conducting of conferences, congresses and symposium related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field
Goods and ServicesPharmaceutical and veterinary preparations for treating cancer, myocardium infarction and malaria; sanitary preparations for medical purposes; biological preparations for medical purposes for the treatment of cancer, myocardium infarction and malaria; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, myocardium infarction and malaria; chemico-pharmaceutical preparations for the treatment of cancer, myocardium infarction and malaria; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of cancer, myocardium infarction and malaria; pharmaceuticals in the nature of anti-cancer preparations
NOT AVAILABLE"NERVIANO MEDICAL SCIENCES" AND "GROUP"
Goods and ServicesScientific, technological, analysis and research services, namely, scientific research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; medical and scientific research, namely, conducting clinical trials for others in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control for others in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, November 26, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNERVIANO MEDICAL SCIENCES S.R.L.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressIT

Party NameNERVIANO MEDICAL SCIENCES S.R.L.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIT

Party NameNERVIANO MEDICAL SCIENCES S.R.L.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIT

Trademark Events


Event DateEvent Description
Thursday, November 25, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 30, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, March 29, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 13, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 23, 2022NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, June 1, 2022NON-FINAL ACTION WRITTEN
Thursday, June 2, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 2, 2022REFUSAL PROCESSED BY MPU
Thursday, June 2, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 22, 2022REFUSAL PROCESSED BY IB
Monday, September 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 12, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, September 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, November 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 30, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 30, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 21, 2022NOTIFICATION PROCESSED BY IB
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Monday, July 10, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 15, 2024NEW REPRESENTATIVE AT IB RECEIVED
Sunday, June 11, 2023GENERIC MADRID TRANSACTION CREATED
Wednesday, June 7, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, June 11, 2023GENERIC MADRID TRANSACTION SENT TO IB